Brought to you by 
Intrinsic Therapeutics grosses $25mm with Series C financing
30 Jan 2003
Executive Summary
Intrinsic Therapeutics (formerly Intrinsic Orthopedics; spinal repair technology) completed its Series C private financing, grossing $25mm. Sprout Group led the round, and was joined by previous investors New Enterprise Associates and Spray Venture Partners.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Intrinsic Therapeutics grosses $25mm with Series C financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice